> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Aileron Therapeutics
- URL: https://www.whiteroseintelligence.com/aileron-therapeutics/
- Published: 1999-01-02T09:09:00.000Z
- Updated: 2024-12-31T20:47:23.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization

**Aileron Therapeutics** is an American biopharmaceutical company based in Cambridge, Massachusetts.

## Organization

| Name           | Position                                                     | Notes                                                                                                                             |
| -------------- | ------------------------------------------------------------ | --------------------------------------------------------------------------------------------------------------------------------- |
| Loren Walensky | Scientific Advisory Board member and consultant[\[1\]](#fn1) | Rochelle Walensky, Dana-Farber Cancer Institute, [Lytica Therapeutics](https://www.whiteroseintelligence.com/Lytica-Therapeutics) |

### Investors

Investors in Aileron Therapeutics include:[\[2\]](#fn2)[\[3\]](#fn3)[\[4\]](#fn4)[\[5\]](#fn5)

- Acorn Bioventures
- Aju IB Investment
- Apple Tree Partners
- BVF Partners
- CB Health Ventures
- Eli Lilly
- Excel Venture Management
- Grand Oaks Capital
- Lincoln Park Capital Fund
- Maven Investment Partners
- Novartis Venture Fund (NVF)
- Roche
- Satter Investment Management
- SR One

## External links

- [Campfire Wiki](https://www.campfire.wiki/doku.php?id=pharmaceutical%5Fcompanies:aileron%5Ftherapeutics)
- [Crunchbase](https://www.crunchbase.com/organization/aileron-therapeutics)
- [Website](https://aileronrx.com/)

---

1. Mourtada, R., Herce, H. D., Yin, D. J., Moroco, J. A., Wales, T. E., Engen, J. R., & Walensky, L. D. (2019). Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice. *Nature Biotechnology, 37*(10), 1186–1197\. <https://doi.org/10.1038/s41587-019-0222-z> [↩︎](#fnref1)
2. *Aileron Therapeutics - Funding, Financials, Valuation & Investors.* Crunchbase. Retrieved May 11, 2023, from <https://www.crunchbase.com/organization/aileron-therapeutics/company%5Ffinancials> [↩︎](#fnref2)
3. *Series A - Aileron Therapeutics - 2006-12-01 - Crunchbase Funding Round Profile.* Crunchbase. Retrieved May 11, 2023, from <https://www.crunchbase.com/funding%5Fround/aileron-therapeutics-series-a--f1823f7a> [↩︎](#fnref3)
4. *Series D - Aileron Therapeutics - 2009-06-11 - Crunchbase Funding Round Profile.* Crunchbase. Retrieved May 11, 2023, from <https://www.crunchbase.com/funding%5Fround/aileron-therapeutics-series-d--7c3c2e71> [↩︎](#fnref4)
5. *Series E - Aileron Therapeutics - 2014-10-29 - Crunchbase Funding Round Profile.* Crunchbase. Retrieved May 11, 2023, from <https://www.crunchbase.com/funding%5Fround/aileron-therapeutics-series-e--740ce9be> [↩︎](#fnref5)